Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Francisco Dr. John L Rubenstein Basic Biology II MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells $1,387,800
Sanford Burnham Prebys Medical Discovery Institute Dr. Huei-sheng Vincent Chen Basic Biology II Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes $1,587,610
University of California, Irvine Dr. Aileen J Anderson Basic Biology II Role of the microenvironment in human iPS and NSC fate and tumorigenesis $1,256,194
Stanford University Dr. Steven Edward Artandi Basic Biology II Self-renewal and senescence in iPS cells derived from patients with a stem cell disease $931,285
Salk Institute for Biological Studies Ronald Mark Evans Basic Biology II Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs $1,712,880
Calimmune, Inc. Geoff Symonds Disease Team Research I GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE $8,278,722
Stanford University Dr. Gary Steinberg Disease Team Research I Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke $17,244,851
University of California, San Diego Dr. Lawrence S. B. Goldstein Disease Team Research I Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis $5,694,308
University of California, Los Angeles Dr. Donald B. Kohn Disease Team Research I Stem Cell Gene Therapy for Sickle Cell Disease $8,833,695
University of California, Los Angeles Dr. Irvin SY Chen Disease Team Research I HPSC based therapy for HIV disease using RNAi to CCR5. $9,905,604
ViaCyte, Inc. Allan Robins Disease Team Research I Cell Therapy for Diabetes $0
Cedars-Sinai Medical Center Eduardo Marbán Disease Team Research I Autologous cardiac-derived cells for advanced ischemic cardiomyopathy $5,560,232
University of California, San Francisco Dr. Mitchel S Berger Disease Team Research I Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM) $6,214,914
City of Hope, Beckman Research Institute Prof. Karen S Aboody M.D. Disease Team Research I Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials $17,890,623
Stanford University Dr. Alfred T Lane Disease Team Research I iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa $11,039,208
Stanford University Professor Irving L Weissman MD Disease Team Research I Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells $18,759,276
University of California, Los Angeles Dr. Dennis J Slamon Disease Team Research I Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors $19,979,660
City of Hope, Beckman Research Institute Prof. John A. Zaia Disease Team Research I ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS $14,536,969
University of Southern California Mark Salman Humayun Disease Team Research I Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) $18,904,916
University of California, San Diego Dr. Dennis A Carson Disease Team Research I Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) $19,999,826
University of California, San Diego Dr. Gene Wei-Ming Yeo Basic Biology I RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency $1,308,901
University of California, San Diego Karl H. Willert Basic Biology I WNT signaling and the control of cell fate decisions in human pluripotent stem cells. $1,329,298
University of California, Davis Dr. Min Zhao Basic Biology I Directing migration of human stem cells with electric fields $816,228
University of California, Los Angeles Dr. Michael A. Teitell Basic Biology I Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer $1,323,029
University of Southern California Dr. Martin Pera Basic Biology I The stem cell microenvironment in the maintenance of pluripotency and reprogramming $1,325,723
Stanford University Dr. Julien Sage Basic Biology I The retinoblastoma (RB) gene family in cellular reprogramming $1,357,085
Stanford University Dr. Susan K McConnell Basic Biology I Identification and characterization of human ES-derived DA neuronal subtypes $1,404,853
University of California, Los Angeles Bennett G Novitch Basic Biology I Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons $1,228,278
University of California, Los Angeles Dr. Robb Maclellan Dr. Basic Biology I Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate $917,667
University of Southern California Dr. Wange Lu Basic Biology I Defining the molecular mechanisms of somatic cell reprogramming $1,365,580
Stanford University Professor Helen M. Blau PhD Basic Biology I Molecular Mechanisms of Reprogramming towards Pluripotency $1,408,332
University of California, Los Angeles Dr. Luisa Iruela-Arispe Basic Biology I Molecular Characterization and Functional Exploration of Hemogenic Endothelium $1,371,477
University of California, Irvine Dr. Aileen J Anderson Quest – Discovery Stage Research Projects Therapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling $2,250,144
Children’s Hospital of Los Angeles Dr Biraj Mahato Quest – Discovery Stage Research Projects Chemically engineered photoreceptors for vision restoration in retinal degeneration associated blindness. $1,711,000
University of California, San Francisco Claire Clelland Quest – Discovery Stage Research Projects Developing a universal CRISPR gene therapy approach to treat C9orf72 ALS $2,740,592
University of California, Los Angeles Dr. Koki Morizono Quest – Discovery Stage Research Projects B cell receptor-mediated lentiviral expression of anti-HIV antibody $2,751,504
University of California, San Francisco Faranak Fattahi Quest – Discovery Stage Research Projects Drug discovery for Charcot Marie Tooth Disease using hPSC-derived Schwann cells $2,471,664
City of Hope, Beckman Research Institute Dr. Christine E. Brown Quest – Discovery Stage Research Projects Development of a Trifunctional Self-Renewing Memory CAR T Cell Therapy to Overcome the Heterogeneity and Suppressive Microenvironment of Glioblastoma $2,700,810
University of California, San Diego Dr. Neil Carson Chi Quest – Discovery Stage Research Projects Modulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies $2,772,000
University of California, San Francisco Dr. Qizhi Tang PhD Quest – Discovery Stage Research Projects Genome editing of human Tregs to enable combinational tolerogenic therapy with T cell-targeted biologics for T1D $2,485,549
Palo Alto Veterans Institute for Research Dr. Jian Luo Quest – Discovery Stage Research Projects Human induced pluripotent stem cells-derived glial enriched progenitors for the treatment of mild traumatic brain injury $2,255,189
Palo Alto Veterans Institute for Research Irene Lorenzo Llorente Quest – Discovery Stage Research Projects Inhibitory interneurons derived from human induced pluripotent stem cells to treat stroke $2,140,122
Savanna Biotherapeutics, Inc. Dr. Sunil Gandhi Ph.D Quest – Discovery Stage Research Projects Gene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) $1,417,948
University of California, San Francisco Faranak Fattahi Quest – Discovery Stage Research Projects Drug discovery for gastrointestinal motility disorders using hPSC-derived enteric ganglioids $1,954,367
University of Southern California Dr. Justin K Ichida Quest – Discovery Stage Research Projects Development of a VAV2 antisense oligonucleotide (ASO) treatment for ALS $2,072,560
Cedars-Sinai Medical Center Dr. Ritchie Ho Quest – Discovery Stage Research Projects C9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy $2,274,768
University of California, Davis Ricardo Anibal Maselli MD Quest – Discovery Stage Research Projects Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy $1,500,000
Adverum Biotechnologies Inc. Cameron Keast Baker Quest – Discovery Stage Research Projects Development of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin $1,150,820
Stanford University Dr. Robert Negrin MD Quest – Discovery Stage Research Projects Orthogonal IL2 Receptor Transduced Regulatory T Cells for Clinical Application $1,920,652
University of California, San Francisco Michael Wilson Quest – Discovery Stage Research Projects A First-in-Class Treatment for Progressive Multifocal Leukoencephalopathy Via Multimodal Immune System Engineering $2,182,396
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 … 32

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More